M. Kulyk & Associates’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-28,337
Closed -$3.4M 108
2025
Q2
$3.4M Buy
28,337
+2,639
+10% +$352K 0.74% 41
2025
Q1
$3.78M Buy
25,698
+979
+4% +$149K 0.87% 40
2024
Q4
$4.01M Sell
24,719
-1,473
-6% -$241K 0.87% 39
2024
Q3
$4.27M Sell
26,192
-310
-1% -$45.9K 0.86% 42
2024
Q2
$3.62M Buy
26,502
+2,446
+10% +$340K 0.84% 41
2024
Q1
$3.68M Buy
24,056
+304
+1% +$45.4K 0.85% 40
2023
Q4
$3.39M Buy
23,752
+607
+3% +$80.9K 0.79% 45
2023
Q3
$3.03M Sell
23,145
-1,951
-8% -$296K 0.84% 42
2023
Q2
$3.99M Sell
25,096
-3,346
-12% -$540K 1.11% 35
2023
Q1
$4.5M Buy
28,442
+308
+1% +$46.2K 1.36% 30
2022
Q4
$3.95M Buy
28,134
+173
+0.6% +$24.6K 1.32% 32
2022
Q3
$3.59M Sell
27,961
-21,009
-43% -$3.03M 1.25% 34
2022
Q2
$6.9M Buy
48,970
+4,084
+9% +$583K 2.15% 13
2022
Q1
$6.24M Buy
44,886
+13,229
+42% +$2.03M 1.7% 16
2021
Q4
$5.52M Buy
31,657
+3,626
+13% +$604K 1.43% 29
2021
Q3
$4.64M Buy
28,031
+2,237
+9% +$385K 1.49% 28
2021
Q2
$4.64M Buy
25,794
+3,135
+14% +$572K 1.68% 25
2021
Q1
$4.37M Buy
22,659
+8,971
+66% +$1.73M 1.63% 20
2020
Q4
$2.76M Buy
+13,688
New +$2.83M 1.53% 33

Other funds holding CLX

M. Kulyk & Associates's CLX Position: Q3 2025 in Review

M. Kulyk & Associates sold out of Clorox (CLX) in Q3 2025, closing a stake of 28,337 shares — an estimated $3.4M sold.

M. Kulyk & Associates first reported a position in CLX in Q4 2020 and held it in 19 quarters. The position peaked at $6.9M in Q2 2022. 1,091 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

  • M. Kulyk & Associates reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
  • M. Kulyk & Associates sold 28,337 Clorox shares in Q3 2025, an estimated $3.4M.
  • M. Kulyk & Associates first reported a position in Clorox in Q4 2020 and held it in 19 quarters.
  • M. Kulyk & Associates's Clorox position peaked at $6.9M in Q2 2022.
  • 1,091 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on M. Kulyk & Associates's 13F filing for Q3 2025, filed 10 Nov 2025.